The emerging role of Toll-like receptor 4 in myocardial inflammation

Cell Death Dis. 2016 May 26;7(5):e2234. doi: 10.1038/cddis.2016.140.

Abstract

Toll-like receptors (TLRs) are a family of pattern recognition receptors involved in cardiovascular diseases. Notably, numerous studies have demonstrated that TLR4 activates the expression of several of pro-inflammatory cytokine genes that play pivotal roles in myocardial inflammation, particularly myocarditis, myocardial infarction, ischemia-reperfusion injury, and heart failure. In addition, TLR4 is an emerging target for anti-inflammatory therapies. Given the significance of TLR4, it would be useful to summarize the current literature on the molecular mechanisms and roles of TLR4 in myocardial inflammation. Thus, in this review, we first introduce the basic knowledge of the TLR4 gene and describe the activation and signaling pathways of TLR4 in myocardial inflammation. Moreover, we highlight the recent progress of research on the involvement of TLR4 in myocardial inflammation. The information reviewed here may be useful to further experimental research and to increase the potential of TLR4 as a therapeutic target.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cardiotonic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Disaccharides / therapeutic use
  • Follistatin / therapeutic use
  • Gene Expression Regulation
  • Heart Failure / drug therapy
  • Heart Failure / genetics
  • Heart Failure / immunology*
  • Heart Failure / pathology
  • Humans
  • Metformin / therapeutic use
  • Myeloid Differentiation Factor 88 / genetics
  • Myeloid Differentiation Factor 88 / immunology
  • Myocardial Infarction / drug therapy
  • Myocardial Infarction / genetics
  • Myocardial Infarction / immunology*
  • Myocardial Infarction / pathology
  • Myocarditis / drug therapy
  • Myocarditis / genetics
  • Myocarditis / immunology*
  • Myocarditis / pathology
  • Myocardium / immunology
  • Myocardium / metabolism
  • Myocardium / pathology
  • NF-kappa B / genetics
  • NF-kappa B / immunology
  • Reperfusion Injury / drug therapy
  • Reperfusion Injury / genetics
  • Reperfusion Injury / immunology*
  • Reperfusion Injury / pathology
  • Signal Transduction
  • Sugar Phosphates / therapeutic use
  • Toll-Like Receptor 4 / antagonists & inhibitors
  • Toll-Like Receptor 4 / genetics
  • Toll-Like Receptor 4 / immunology*

Substances

  • Cardiotonic Agents
  • Disaccharides
  • Follistatin
  • MYD88 protein, human
  • Myeloid Differentiation Factor 88
  • NF-kappa B
  • Sugar Phosphates
  • Toll-Like Receptor 4
  • eritoran
  • Metformin